RMD Instruments Announces Import & Distribution Agreement With Sugan & Sheen-Man for Navigator™ System & Surgical Probes in...
19 Octubre 2010 - 8:14AM
Business Wire
RMD Instruments Corp, a wholly owned subsidiary of Dynasil
Corporation of America (OTCBB:DYSL) today announced the appointment
of Sugan Co., LTD. (Japan) and Sheen-Man Co. Ltd (Japan) as the
exclusive marketing manager and distributor, respectively, to Japan
markets for RMD’s Navigator™ system and gamma surgical probes for
advanced cancer detection and evaluation, which help doctors more
accurately locate cancer cells for targeted therapy.
Mark Caldwell, General Manager of RMD, commented “We are excited
to accelerate our presence into the Japanese market with our
Navigator™ GPS line of products which provides gamma localization
of tissue during surgery. The system and mapping probes are
intended for use in localizing suspected cancer lesions not visible
with other imaging modalities, providing early detection and
evaluation of disease extent. We think the combination of Sugan and
Sheen-Man, together with our Navigator GPS product line, will be a
winning combination in expanding important distribution channels
throughout Japan.”
As an importer, Sugan Co. LTD, (established in 1988), acts as
the local marketing and regulatory presence, and an importer, while
corresponding with overseas manufacturers. They manage regulatory
issues, and communicate with government agencies and hospitals.
Sheen-Man Co., (established in 1974), has been selling and
distributing radiology products using its own distribution channels
throughout Japan and is a respected distributor in this important
region. Sheen-Man also has a technical support group for
installation and servicing of medical equipment.
Jim Lovejoy, General Sales Manager, of RMD’s medical products,
states: “We are pleased to announce the continued expansion of our
global distribution network. Partnering with Sugan and Sheen-Man
will enable RMD and Dynasil to expand into the Japanese market
segment. Our Navigator™ product portfolio is an excellent
complement to Sugan’s and Sheen-Man’s medical device
initiatives.”
“We are thrilled to be representing a US manufacturer with state
of the art technology, extensive research and development and a
product line that benefits both the patient and the surgeon,”
stated Atsushi Sugahara, President and CEO of Sugan Co. Ltd.
Both Sugan Co. Ltd. and Sheen-Man Co. Ltd., are headquartered in
Osaka, with Sales Offices in Tokyo and Kyushu.
About RMD Instruments Corp.:
RMD Instruments Corp (RMD), a wholly owned subsidiary of Dynasil
Corporation of America, is a diversified technology company
providing innovative products to a wide range of markets and
disciplines. The company has a rich history of applying science and
research to develop products that improve healthcare, enhance
security and deliver advanced solutions to businesses around the
world. RMD has been producing the Navigator™ GPS Lymphatic Mapping
System since 1999. RMD is based in Watertown, Massachusetts.
About Dynasil: Dynasil Corporation of America
(OTCBB:DYSL), is a provider of technology, products, services and
solutions aimed at making the world safer and healthier. The
company supplies a broad range of customers by serving their
specific needs in the medical, industrial, and homeland
security/defense markets. The Company has operations in New Jersey,
New York, Massachusetts and the UK.
This news release may contain forward-looking statements usually
containing the words "believe," "expect," “plan”, “target”,
“intend” or similar expressions. These statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act. Future results of operations, projections, and
expectations, which may relate to this release, involve certain
risks and uncertainties that could cause actual results to differ
materially from the forward-looking statements. Factors that would
cause or contribute to such differences include, but are not
limited to, the factors detailed in the Company's Annual Report or
Form 10-K and in the Company's other Securities and Exchange
Commission filings, continuation of existing market conditions and
demand for our products. Dynasil undertakes no obligation to update
these forward-looking statements to reflect actual results, changes
in assumptions or changes in other factors that may affect such
forward-looking statements
Dynasil Corp of America (CE) (USOTC:DYSL)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Dynasil Corp of America (CE) (USOTC:DYSL)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024